Daxor Corporation Awarded $1.9M Two-Year Contract From U.S. Air Force To Develop Next-Generation Point-Of-Care Blood Volume Analyzer Using Novel Fluorescent Tracer And Optical Sensing Technology
Portfolio Pulse from Benzinga Newsdesk
Daxor Corporation has been awarded a $1.9 million two-year contract from the U.S. Air Force to develop a next-generation point-of-care blood volume analyzer using novel fluorescent tracer and optical sensing technology.

August 06, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Daxor Corporation has secured a $1.9 million contract from the U.S. Air Force to develop a next-generation blood volume analyzer, which could enhance its product offerings and revenue streams.
The contract from the U.S. Air Force is a significant endorsement of Daxor's technology and could lead to increased revenue and enhanced product offerings. This development is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100